VASOACTIVE DRUGS FOR HEPATORENAL SYNDROME: A META-ANALYSIS

被引：0
|
作者：
Israelsen, M. E. [1 ,2 ]
Allegretti, A. S. [3 ]
Krag, A. [1 ]
Jovani, M. [4 ]
Goldin, A. H. [5 ]
Schulman, A. [5 ]
Gluud, L. L. [2 ]
机构：
[1] Odense Univ Hosp, Dept Gastroenterol & Hepatol, Odense, Denmark
[2] Univ Copenhagen, Hvidovre Hosp, Div Med, Gastrounit, Hvidovre, Denmark
[3] Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02114 USA
[4] Harvard Sch Publ Hlth, Boston, MA USA
[5] Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy, 75 Francis St, Boston, MA 02115 USA
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
10.1016/S0168-8278(16)01245-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-024
引用
收藏
页码：S662 / S662
页数：1
相关论文
共 50 条
  • [1] VASOACTIVE DRUGS FOR HEPATORENAL SYNDROME: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED TRIALS
    Gluud, Lise L.
    Christensen, Kurt
    Christensen, Erik
    Krag, Aleksander
    HEPATOLOGY, 2009, 50 (04) : 469A - 469A
  • [2] Systematic review with meta-analysis: vasoactive drugs for the treatment of hepatorenal syndrome type 1
    Gifford, F. J.
    Morling, J. R.
    Fallowfield, J. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (05) : 593 - 603
  • [3] The Comparative Effectiveness of Vasoactive Treatments for Hepatorenal Syndrome: A Systematic Review and Network Meta-Analysis
    Pitre, Tyler
    Kiflen, Michel
    Helmeczi, Wryan
    Dionne, Joanna C.
    Rewa, Oleksa
    Bagshaw, Sean M.
    Needham-Nethercott, Natalie
    Alhazzani, Waleed
    Zeraatkar, Dena
    Rochwerg, Bram
    CRITICAL CARE MEDICINE, 2022, 50 (10) : 1419 - 1429
  • [4] Terlipressin versus other vasoactive drugs for hepatorenal syndrome
    Israelsen, Mads
    Krag, Aleksander
    Allegretti, Andrew S.
    Jovani, Manol
    Goldin, Alison H.
    Winter, Rachel W.
    Gluud, Lise Lotte
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (09):
  • [5] Meta-analysis: terlipressin therapy for the hepatorenal syndrome
    Fabrizi, F.
    Dixit, V.
    Martin, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (06) : 935 - 944
  • [6] Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis
    Mirela Dobre
    Sevag Demirjian
    Ashwini R. Sehgal
    Sankar D. Navaneethan
    International Urology and Nephrology, 2011, 43 : 175 - 184
  • [7] Pharmacological treatment of hepatorenal syndrome: a network meta-analysis
    Wang, Li
    Long, Yin
    Li, Ke-Xin
    Xu, Gao-Si
    GASTROENTEROLOGY REPORT, 2020, 8 (02): : 111 - 118
  • [8] Terlipressin for hepatorenal syndrome: A meta-analysis of randomized trials
    Fabrizi, Fabrizio
    Dixit, Vivek
    Messa, Piergiorgio
    Martin, Paul
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2009, 32 (03): : 133 - 140
  • [9] Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis
    Dobre, Mirela
    Demirjian, Sevag
    Sehgal, Ashwini R.
    Navaneethan, Sankar D.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2011, 43 (01) : 175 - 184
  • [10] Vasoactive Agents for Hepatorenal Syndrome: A Mixed Treatment Comparison Network Meta-Analysis and Trial Sequential Analysis of Randomized Clinical Trials
    Sridharan, Kannan
    Sivaramakrishnan, Gowri
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 (01) : 97 - 102
12345